Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTX-4975 Extension in Morton's Neuroma
NCT02678793Phase 2Completed
- Sponsor
- Centrexion Therapeutics
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin in Morton's neuroma, sponsored by Centrexion Therapeutics. Started Dec 2015; status: completed.
02
Drugs
capsaicin
03
Conditions
Morton's neuroma
Beyond the preview
Go deeper on NCT02678793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678793.